Clinical Study

Neuroimaging Study For Children And Adolescents With Adhd

Posted Date: May 16, 2018

  • Investigator: Melissa Delbello
  • Specialties:
  • Type of Study: Drug

The main purpose of this study is to see the effects of the study medication called MAS-XR on brain function by taking brain pictures. The researchers also want to see if MAS-XR makes your child more or less likely to develop problems like acting out (i.e. aggression). MAS-XR is approved by the U.S. FDA to treat ADHD in adults and in children and adolescents. By completing this study, we hope to better understand how MAS-XR affects brain function. With this information, we hope to be able to improve treatment and clinical outcomes for people with ADHD.

Criteria:

Your Child Is Being Asked To Take Part In This Research Study Because He/She Is 10 To 18 Years Of Age (Inclusive) And Has Been Diagnosed With Adhd (Inattentive, Hyperactive/Impulsive, Or Combined Type) And Is Not Currently Taking A Psychostimulant Medication.

Keywords:

Psychiatry, Adhd, Child, Adolescent, Null

For More Information:

Laura Mclaughlin
(513) 558-6205
mclaugle@ucmail.uc.edu